Host: Peter K. Kaiser, MD Guest: Dante J. Pieramici, MD Correctly identifying retinal diseases early on is essential in preserving your patients’ vision. How do physicians distinguish key pathological features to identify early neovascular age-rela

Host: Emily Chew, MD Guest: Neil Bressler, MD Guest: Joseph M. Coney, MD Guest: Steven Ferrucci, OD, FAAO Approximately 2 million individuals in the United States are living with age-related macular degeneration (AMD), and another 1.6 million a

Host: Michael S. Ip, MD Guest: Christina Y. Weng, MD, MBA For patients with retinal vascular disease, time is vision. But there are key components that can help you diagnose early neovascular age-related macular degeneration and retinal vein occlus

Host: Neilanjan Nandi, MD Guest: Gary R. Lichtenstein, MD, FACG, FACP, AGAF Achieving remission and long-term success in IBD is greatly dependent on developing a treatment plan that incorporates therapies that induce mucosal healing, reduce inflamm

Host: Patricia K. Coyle, MD Guest: Jiwon Oh, MD Treatment goals for patients with multiple sclerosis continue to be refined as more and better disease-modifying drugs emerge from clinical trials and we accrue findings from real-world data. Nonethel

Host: Neilanjan Nandi, MD Guest: Miguel Regueiro, MD, AGAF Treat-to-target is the current standard for the management of IBD, and as such it is imperative to understand what those targets are, what strategies will help you achieve them, and the imp

Host: Patricia K. Coyle, MD Guest: Mitzi Joi Williams, MD While we are witnessing an impressive expansion in the multiple sclerosis treatment landscape, we cannot lose sight of the fact that a critical component of care is the incorporation of best

Host: Azeem Latif, MD Guest: Sarah Kohnstamm, MD, FACC New guidelines on valvular heart disease from the American Heart Association and the American College of Cardiology have recently been published. In this activity, Dr. Latib and Dr. Kohnstamm d

Host: Joel L. Cohen, MD Guest: Carolyn I. Jacob, MD, FAAD What does the future hold for aesthetics? The 4 four available neuromodulators share a similar mechanism of action and efficacy profiles, but they each have their own unique characteristics,

Guest: Joseph Mikhael, MD, MEd, FRCPC, FACP A 15-minute synopsis of the top hematology research in multiple myeloma presented at the 2020 ASH Annual Meeting. Learn about potential practice-changing data placed in a real-world context by a myeloma exp